Survey Reveals Increased Reliance On Observational Research Among Life Sciences Companies

More pharmaceutical, medical device and biotech companies are seeking evidence on how their products perform under actual practice conditions.

CHICAGO--()--New research has revealed that more life sciences companies are relying on observational research studies than ever before. Ten-year aggregate results from the Annual Survey on Observational Research conducted by Continuum Clinical were released in a white paper today.

Among the findings, the survey revealed that 70% of companies surveyed either have a department or specific individuals dedicated to observational research, and an additional 19% are in the process of evaluating the need for organizational specialization.

“This finding is in stark contrast to the lack of focus and experience that inspired development of the survey several years ago,” said Jeff Trotter, President of Continuum Clinical. “Life sciences companies have clearly recognized that observational studies are critical for generating real-world evidence of clinical, economic, and humanistic value, and have responded with an increased focus internally.”

Unlike pre-approval clinical trials designed for regulatory approval, observational studies respond to the need for outcomes data on how diseases are managed or how drugs and devices are utilized under actual practice conditions.

“Prior surveys revealed sponsoring companies often imposed operational and organizational constraints on observational studies that reflected greater ‘comfort’ for the processes underlying interventional clinical trials,” said Trotter. “While there is an increase in building centers of excellence around this activity, there is still room for growth around the correct business strategy for observational research and how these critical studies are designed and implemented.”

The eleventh version of the Survey on Observational Research will be released for participation in early 2017, and will feature an increased focus on the use of advanced technology in the generation and communication of real-world evidence.

About Continuum Clinical

Continuum Clinical is a global healthcare research and communications company. With over thirty years of experience, Continuum Clinical brings together a unique blend of world-class experience in key disciplines, including observational research, marketing, communications, health economics, and outcomes research. We excel in providing seamless resources for pharmaceutical and biotech products — from patient recruitment and retention for clinical trials to late stage studies and health economics and outcomes research. Continuum Clinical provides a unique blend of resources and perspectives, proven expertise, and innovative solutions throughout the entire continuum of a product’s lifecycle — from pre-launch into the real world. Headquartered in the US, Continuum Clinical has employees in Europe and expanded worldwide network of resources.

WWW.CONTINUUMCLINICAL.COM

Contacts

Josh McColough
Director, Corporate Communications
Continuum Clinical
jmccolough@continuumclinical.com
847-418-2474

Contacts

Josh McColough
Director, Corporate Communications
Continuum Clinical
jmccolough@continuumclinical.com
847-418-2474